Dialysis Drug Reference Products for Clinical Use

Dialysis of Drugs is a clinical reference used to guide medication dosing and dialyzability decisions in patients receiving hemodialysis and peritoneal dialysis. It is used by pharmacists, nephrologists, and healthcare teams at the point of care.


Due to increased cost of mailing internationally, we strongly recommend those outside the US subscribe to the Dialysis of Drugs mobile app, available for iOS and Android devices, rather than ordering a print version.

2026 Dialysis of Drugs Search Graphic

$22 Per Year*

Dialysis of Drugs App

 

The Dialysis of Drugs app for iOS and Android provides quick, evidence-based information on the dialyzability of over 2,200 medications in patients receiving hemodialysis or peritoneal dialysis. Search by brand or generic name; now auto-renews annually with the option to cancel anytime.

*These prices remain the same as for the 2024 edition.

Bailie and Mason's 2026 Dialysis of Drugs Cover Image

$24 + S&H*

Dialysis of Drugs Pocket Guide

The Dialysis of Drugs printed pocket guide is a 68-page, pocket-sized booklet (3.75 x 6.5 inches) that provides quick, literature-based information on the dialyzability of over 2,200 medications. Perfect for on-the-go reference in clinical settings.

*These prices remain the same as for the 2024 edition.

2026 Dialysis of Drugs Wall Chart Image

$26 + S&H

Dialysis of Drugs Wall Chart

The Dialysis of Drugs printed wall chart (24 x 38.5 inches) offers a clear, at-a-glance reference for the dialyzability of over 2,200 medications. Ideal for display in clinical settings, it provides quick access to essential drug information for healthcare professionals.

Bailie and Mason's Dialysis of Drugs Logo

Institutional Site License

RPC is pleased to offer contracts for institutional use of Dialysis of Drugs. We would provide you with a PDF version that can be posted on your intranet for unlimited use. These site licenses may be annual or multi-year and can be structured for automatic renewal. Prices are dependent on factors such as institutional size, number of users and country of use (for example, other countries may have different healthcare financial structures from the US, as well as varying rates of exchange). In all cases, we endeavor to work with prospective clients to create a fee that is mutually agreeable. Typical annual fees range from $500 to $2,500. Please contact us for more information.

Email: nmason@dialysisofdrugs.com
Renal Pharmacy Consultants